Ron Diskin
13Patents
4h-index
4Co-inventors
49Inventor score
Filing activity: May 17, 2012 → Mar 6, 2024
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US9493549B2 | Antibodies directed toward the HIV-1 GP120 CD4 binding site with increased potency and breadth | Chemistry; Metallurgy | 12 | Active |
| US9890207B2 | Highly active agonistic CD4 binding site anti-HIV antibodies (HAADS) comprising modified CDRH2 regions that improve contact with GP120 | Chemistry; Metallurgy | 10 | Active |
| US9879068B2 | Antibodies targeting HIV escape mutants | Chemistry; Metallurgy | 7 | Active |
| US9783594B2 | Human immunodeficiency virus neutralizing antibodies and methods of use thereof | Chemistry; Metallurgy | 7 | Active |
| US11149081B2 | HIV-1 GP120 CD4 binding site antibodies targeting HIV escape mutants | Chemistry; Metallurgy | 3 | Active |
| US10590187B2 | Highly active agonistic CD4 binding site anti-HIV antibodies (HAADS) comprising modified CDRH2 regions that improve contact with gp120 | Chemistry; Metallurgy | 1 | Active |
| US12071470B2 | Human immunodeficiency virus neutralizing antibodies and methods of use thereof | Chemistry; Metallurgy | 1 | Active |
| US12173052B2 | HIV-1 gp120 CD4 binding site antibodies targeting HIV escape mutants | Chemistry; Metallurgy | 0 | Active |
| US11472868B2 | Highly active agonistic CD4 binding site anti-HIV antibodies (HAADS) comprising modified CDRH2 regions that improve contact with GP120 | Chemistry; Metallurgy | 0 | Active |
| US12054538B2 | Highly active agonistic CD4 binding site anti-HIV antibodies (HAADS) comprising modified CDRH2 regions that improve contact with GP120 | Chemistry; Metallurgy | 0 | Active |
| US12428472B2 | Human immunodeficiency virus neutralizing antibodies and methods of use thereof | Chemistry; Metallurgy | 0 | Active |
| US11634478B2 | Human immunodeficiency virus neutralizing antibodies and methods of use thereof | Chemistry; Metallurgy | 0 | Active |
| US10889633B2 | Human immunodeficiency virus neutralizing antibodies and methods of use thereof | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.